James M. Meer - 03 Jan 2022 Form 4 Insider Report for Elanco Animal Health Inc (ELAN)

Signature
/s/ Marcela A. Kirberger, Attorney-in-Fact for James M. Meer
Issuer symbol
ELAN
Transactions as of
03 Jan 2022
Net transactions value
-$57,010
Form type
4
Filing time
05 Jan 2023, 17:32:08 UTC
Previous filing
04 Jun 2021
Next filing
03 Mar 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ELAN Common Stock Award $0 +3,540 +32% $0.000000 14,607 03 Jan 2022 Direct F1
transaction ELAN Common Stock Award $0 +3,683 +25% $0.000000 18,290 22 Feb 2022 Direct F2
transaction ELAN Common Stock Tax liability $32,813 -1,263 -6.9% $25.98 17,027 22 Feb 2022 Direct F3
transaction ELAN Common Stock Award $0 +2,955 +17% $0.000000 19,982 01 Mar 2022 Direct F4
transaction ELAN Common Stock Tax liability $11,084 -383 -1.9% $28.94 19,599 01 Mar 2022 Direct F5
transaction ELAN Common Stock Tax liability $8,149 -281 -1.4% $29.00 19,318 02 Mar 2022 Direct F5
transaction ELAN Common Stock Tax liability $4,965 -402 -2.1% $12.35 18,916 03 Jan 2023 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of restricted stock units pursuant to the 2018 Elanco Stock Plan on January 3, 2022, one-third vesting on January 3, 2023, one-third vesting on January 3, 2024, and the remaining vesting on January 3, 2025.
F2 Vesting of performance-based restricted stock units granted under the 2018 Elanco Stock Plan.
F3 Represents shares tendered to the Company to cover the Reporting Person's tax liability upon vesting of performance-based restricted stock units granted under the 2018 Elanco Stock Plan.
F4 Grant of restricted stock units pursuant to the 2018 Elanco Stock Plan on March 1, 2022, one-third vesting on March 1, 2023, one-third vesting on March 1, 2024, and the remaining vesting on March 1, 2025.
F5 Represents shares tendered to the Company to cover the Reporting Person's tax liability upon vesting of restricted stock units previously awarded under the 2018 Elanco Stock Plan.